Optimal Treatment of Unresectable, Stage III NSCLC

Download this slideset to review key clinical data guiding optimal treatment of patients with unresectable, stage III NSCLC, including an expert case discussion and future directions.
H. Jack West, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 466 KB
Released: May 31, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Nivolumab plus ipilimumab, with or without chemotherapy, is now approved for advanced NSCLC. Read this expert commentary from CCO on how to best use these regimens in clinical practice.

Stephen V. Liu, MD Released: July 6, 2020

Mary Jo Fidler, MD discusses key data in lung malignancies from ASCO 2020 and optimization of therapeutic benefit through management of cancer cachexia syndrome

person default Mary Jo Fidler, MD Released: June 30, 2020

Gain key clinical insights fast, with this short slideset from CCO on new biomarkers critical to lung cancer care today

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 26, 2020

Downloadable slideset reviewing new and emerging molecular targets critical to lung cancer care, from Clinical Care Options (CCO)

Leora Horn, MD, MSc, FRCPC Edward S. Kim, MD, FACP Released: June 25, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?